B G P Healthcare Private Limited — Nicotine Exporter Profile
Indian Pharmaceutical Exporter · #2 for Nicotine · $1.1M export value · DGFT Verified
B G P Healthcare Private Limited is the #2 Indian exporter of Nicotine with $1.1M in export value and 21 verified shipments. B G P Healthcare Private Limited holds a 7.0% market share in Nicotine exports across 2 countries.
B G P Healthcare Private Limited — Nicotine Export Profile: Buyers & Destinations
Where Does B G P Healthcare Private Limited Export Nicotine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $650.8K | 17 | 76.5% |
| SPAIN | $200.0K | 4 | 23.5% |
B G P Healthcare Private Limited exports Nicotine to 2 countries. The largest destination is UNITED STATES accounting for 76.5% of B G P Healthcare Private Limited's Nicotine shipments. These destinations reflect B G P Healthcare Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Nicotine from B G P Healthcare Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER | UNITED STATES | $50.0K | 1 |
| TO ORDER | UNITED STATES | $50.0K | 1 |
B G P Healthcare Private Limited supplies Nicotine to 2 buyers globally. The largest buyer is TO THE ORDER (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Nicotine Export Value and How Much Does B G P Healthcare Private Limited Contribute?
India exported $6.8M worth of Nicotine through 837 shipments from 61 suppliers to 34 countries, serving 100 buyers globally. B G P Healthcare Private Limited contributes $1.1M to this total, accounting for 7.0% of India's Nicotine exports. B G P Healthcare Private Limited ships Nicotine to 2 countries through 2 buyers.
What Is the Average Shipment Value for B G P Healthcare Private Limited's Nicotine Exports?
B G P Healthcare Private Limited's average Nicotine shipment value is $50.0K per consignment, based on 21 shipments totaling $1.1M. The largest destination is UNITED STATES (76.5% of B G P Healthcare Private Limited's Nicotine exports).
How Does B G P Healthcare Private Limited Compare to Other Indian Nicotine Exporters?
B G P Healthcare Private Limited ranks #2 among 61 Indian Nicotine exporters with a 7.0% market share. The top 3 exporters are RUBICON RESEARCH PRIVATE LIMITED ($4.7M), B G P HEALTHCARE PRIVATE LIMITED ($1.1M), HARSH NUTRICARE PRIVATE LIMITED ($532.5K). B G P Healthcare Private Limited processed 21 shipments to 2 destination countries.
What Nicotine Formulations Does B G P Healthcare Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| NICOTINE POLACRILEX USP (CONTAIN 20% NIC | $200.0K | 4 |
| NICOTINE POLACRILEX USP (CONTAIN 20% NICOTINE) | $100.3K | 3 |
| NICOTINE POLACRILEX USP CONTAIN 20 NICOTINE | $100.1K | 3 |
| NICOTINE POLACRILEX USP | $50.2K | 2 |
| NICOTINE POLACRILEX USP (CONTAIN 20% NICOTINE) [CAS NO. 96055-45-7] B.NO.NP003/25 TO NP011/25 MFG.DT.01/2025,EXP.DT.01/2 | $50.2K | 2 |
| NICOTINE POLACRILEX USP(CONTAIN 20%NICOT | $50.0K | 1 |
| NICOTNE POLACRILEX USP/NICOTINE RESINATE | $50.0K | 1 |
| NICOTINE POLACRILEX CONTAINS 20 NICOTINE | $50.0K | 1 |
| NICOTINE POLACRILEX USP/NICOTINE RESINAT | $50.0K | 1 |
| NICOTINE POLACRILEX USP/NICOTINE RESINATE EP(CONTAIN 20% NICOTINE),B#NP072/23 TONP073/23,MFG.DT.12/2023,EXP.DT.12/2028 | $50.0K | 1 |
B G P Healthcare Private Limited exports 12 distinct Nicotine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is NICOTINE POLACRILEX USP (CONTAIN 20% NIC with 4 shipments worth $200.0K.
Regulatory Requirements: Exporting Nicotine to Key Markets
What B G P Healthcare Private Limited must comply with to export Nicotine to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does B G P Healthcare Private Limited Compare to Nearest Nicotine Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | RUBICON RESEARCH PRIVATE LIMITED | $4.7M | 94 | 1 | $50.0K |
| 2 | B G P HEALTHCARE PRIVATE LIMITED ★ | $1.1M | 21 | 2 | $50.0K |
| 3 | HARSH NUTRICARE PRIVATE LIMITED | $532.5K | 116 | 5 | $4.6K |
| 4 | D.RIKU TAZGI EXIM LLP | $162.0K | 63 | 2 | $2.6K |
B G P Healthcare Private Limited ranks #2 among 61 Indian Nicotine exporters. Average shipment value of $50.0K compared to the market average of $110.9K. The closest competitors by value are RUBICON RESEARCH PRIVATE LIMITED and HARSH NUTRICARE PRIVATE LIMITED.
Which Indian Ports Ship Nicotine Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 157 | 18.8% |
| DELHI AIR | 141 | 16.8% |
| SAHAR AIR CARGO ACC (INBOM4) | 134 | 16.0% |
| SAHAR AIR | 78 | 9.3% |
| NHAVA SHEVA SEA (INNSA1) | 71 | 8.5% |
| Bombay Air | 35 | 4.2% |
| CHENNAI AIR CARGO ACC (INMAA4) | 25 | 3.0% |
| Bombay Air Cargo | 22 | 2.6% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Nicotine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Nicotine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: B G P Healthcare Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 21 individual customs records matching B G P Healthcare Private Limited exporting Nicotine, covering 12 formulations to 2 countries via 2 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 34+ countries, 100+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Nicotine Export Data from B G P Healthcare Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for B G P Healthcare Private Limited's Nicotine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
B G P Healthcare Private Limited
Company Profile
0 products · $0 total trade · 0 categories
Nicotine Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for B G P Healthcare Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Nicotine. For current shipment-level data, contact TransData Nexus.